RW40 Stock Overview
A technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Silex Systems Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$17.70 |
52 Week High | AU$20.00 |
52 Week Low | AU$10.20 |
Beta | 0.87 |
11 Month Change | 14.19% |
3 Month Change | 40.48% |
1 Year Change | 66.98% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 250.22% |
Recent News & Updates
Recent updates
Shareholder Returns
RW40 | DE Machinery | DE Market | |
---|---|---|---|
7D | 5.4% | -2.4% | -0.4% |
1Y | 67.0% | 18.5% | 7.1% |
Return vs Industry: RW40 exceeded the German Machinery industry which returned 20% over the past year.
Return vs Market: RW40 exceeded the German Market which returned 7.8% over the past year.
Price Volatility
RW40 volatility | |
---|---|
RW40 Average Weekly Movement | 4.7% |
Machinery Industry Average Movement | 4.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RW40 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: RW40's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | n/a | Michael Goldsworthy | www.silex.com.au |
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. The company operates in three segments: Silex Systems, Translucent, and Silex USA. The company sells its cREO technology; and develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies.
Silex Systems Limited Fundamentals Summary
RW40 fundamental statistics | |
---|---|
Market cap | €882.52m |
Earnings (TTM) | -€14.02m |
Revenue (TTM) | €6.91m |
127.8x
P/S Ratio-62.9x
P/E RatioIs RW40 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RW40 income statement (TTM) | |
---|---|
Revenue | AU$11.20m |
Cost of Revenue | AU$12.91m |
Gross Profit | -AU$1.71m |
Other Expenses | AU$21.02m |
Earnings | -AU$22.73m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.096 |
Gross Margin | -15.30% |
Net Profit Margin | -203.02% |
Debt/Equity Ratio | 0% |
How did RW40 perform over the long term?
See historical performance and comparison